Ropivacaine in the horse: its pharmacological responses, urinary detection and mass spectral confirmation.

The research investigates the effects, urinary detection, and specific identification of the anesthetic ropivacaine in horses. It found that ropivacaine is a strong local anesthetic, detectable in urine after administration, and its main metabolite, post administration, is 3-hydroxyropivacaine.

Pharmacological Responses of Ropivacaine

• This section of the study observed the effects of ropivacaine, a potent local anesthetic recently introduced into human medicine, when used on horses. In their tests, the researchers found that the estimated highest no-effect dose (HNED) in horses was approximately 0.4 mg/site.

Urinary Detection of Ropivacaine

• The research also included the urinary detection of ropivacaine using ELISA screening, a technique typically employed to quantify substances such as peptides, proteins, antibodies, and hormones.
• Clinically effective doses of ropivacaine could be identified through ELISA screening after being administered to the horses.

Mass Spectral Confirmation of Ropivacaine

• In this part of the study, mass spectral analyses were utilized to identify specific compounds present in post-administration urine samples.
• Although they could not detect unchanged ropivacaine in the urine samples, a substance indistinguishable from 3-hydroxyropivacaine, an authentic metabolite of ropivacaine, was found.

Summary of Findings

• The researchers concluded that ropivacaine is a potent LA for use in equine medicine.
• It was also established that ropivacaine can be readily detected in postadministration samples via ELISA-based screening methods.
• The primary metabolite in post-administration urine samples was identified as 3-hydroxyropivacaine, a verified metabolite of ropivacaine, further confirming the presence and metabolism of the anesthetic in horses.